Index your Journal on RJRIndex — A product by ResearchJournalRank.com Index Now
34,970+ Journals Indexed Journal Suggester  |  Paper Finder  |  Compare Journals
Home › Molecular Cancer Therapeutics

Molecular Cancer Therapeutics

Q1 Journal Scopus Active Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└ Cancer Research Q1
└ Oncology Q1
SJR 2025
2.392
Q1
SJR Score
H-Index
212
Citations / Doc (2yr)
5.55
Total Docs. (latest)
155
Total Citations (3yr)
2,514
Publication type
Journals
ISSN
15357163, 15388514
Coverage
2001-2026
Journal Rank
#1,046
Advertisement

Subject Categories

Cancer Research Q1
Oncology Q1

Aims & Scope

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer Therapeutics, Identification of Molecular Targets, Targets for Chemoprevention, New Models, Cancer Chemistry and Drug Discovery, Molecular and Cellular Pharmacology, Molecular Classification of Tumors, and Bioinformatics and Computational Molecular Biology. The journal provides a publication forum for these emerging disciplines that is focused specifically on cancer research. Papers are stringently reviewed and only those that report results of novel, timely, and significant research and meet high standards of scientific merit will be accepted for publication.

Abstracting & Indexing

Scopus Google Scholar Web of Science Medline Embase

Detailed Metrics

Total Docs. (latest) 155
Total Docs. (3 years) 433
Total Refs. 8,459
Total Citations (3 years) 2,514
Citable Docs. (3 years) 425
Citations / Doc. (2 years) 5.55
Ref. / Doc. 54.57
% Female 43.0%

Metrics Visualization

Latest year data vs 3-year cumulative figures

Publication & Citation Trend

Loading trend data from Crossref...

Top 10 Most Cited Articles

Loading articles...

Frequently Asked Questions

What is the impact factor of Molecular Cancer Therapeutics?

The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Molecular Cancer Therapeutics has an SJR of 2.392 and is ranked Q1.

What is the SJR and quartile of Molecular Cancer Therapeutics?

Molecular Cancer Therapeutics has an SJR (SCImago Journal Rank) of 2.392 and its best quartile is Q1.

What is the H-index of Molecular Cancer Therapeutics?

The H-index of Molecular Cancer Therapeutics is 212, meaning 212 of its articles have each been cited at least 212 times.

Is Molecular Cancer Therapeutics indexed in Scopus?

Yes. Molecular Cancer Therapeutics is active in Scopus (Scopus Source List, August 2026).

Advertisement

Journal Information

SJR2.392
Best QuartileQ1
H Index212
ISSN15357163, 15388514
PublisherAmerican Association for Cancer Research Inc.
CountryUnited States
RegionNorthern America
Coverage2001-2026
Open AccessNo
TypeJournal
Rank#1,046

Similar Journals

View all Biochemistry, Genetics and Molecular Biology journals

Embed This Journal

Add this journal's ranking badge to your website:

<iframe src="https://researchjournalrank.com/widget.php?id=962" style="border:1px solid #e0e0e0;border-radius:8px;width:100%;max-width:320px;height:200px" frameborder="0"></iframe>
Preview:

Researcher Reviews

Write a Review

No reviews yet for this journal.

Be the first to share your experience!

Share Your Experience

Your review will be published after moderation. Email will not be displayed publicly.

★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★
★ ★ ★ ★ ★